Resveratrol and Quercetin Cooperate to Induce Senescence-like Growth Arrest in C6 Rat Glioma Cells

Overview

Journal Cancer Sci

Specialty Oncology

Date 2009 Jun 6

PMID 19496785

Citations 50

Authors

Lauren L Zamin

Eduardo C Filippi-Chiela

Patricia Dillenburg-Pilla

Fabiana Horn

Christianne Salbego

Guido Lenz

Affiliations

Soon will be listed here.

Abstract

Glioma is the most frequent and malignant primary human brain tumor with dismal prognosis despite multimodal therapy. Resveratrol and quercetin, two structurally related and naturally occurring polyphenols, are proposed to have anticancer effects. We report here that resveratrol and quercetin decreased the cell number in four glioma cell lines but not in rat astrocytes. Low doses of resveratrol (10 microM) or quercetin (25 microM) separately had no effect on apoptosis induction, but had a strong effect on caspase 3/7 activation when administered together. Western blot analyses showed that resveratrol (10 microM) and quercetin (25 microM) caused a reduction in phosphorylation of Akt, but this reduction was not sufficient by itself to mediate the effects of these polyphenols. Most important, resveratrol and quercetin chronically administered presented a strong synergism in inducing senescence-like growth arrest. These results suggest that the combination of polyphenols can potentialize their antitumoral activity, thereby reducing the therapeutic concentration needed for glioma treatment.

Citing Articles

Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms.

Singaravelan N, Tollefsbol T Nutrients. 2025; 17(4).

PMID: 40004944 PMC: 11858336. DOI: 10.3390/nu17040616.

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.

Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y Exp Hematol Oncol. 2025; 14(1):8.

PMID: 39871386 PMC: 11771031. DOI: 10.1186/s40164-025-00597-9.

Cytotoxicity, Proapoptotic Activity and Drug-like Potential of Quercetin and Kaempferol in Glioblastoma Cells: Preclinical Insights.

Kusaczuk M, Tovar-Ambel E, Martin-Cabrera P, Lorente M, Salvador-Tormo N, Miklosz A Int J Mol Sci. 2024; 25(19).

PMID: 39409069 PMC: 11477293. DOI: 10.3390/ijms251910740.

Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms.

Sheida A, Farshadi M, Mirzaei A, Najjar Khalilabad S, Zarepour F, Taghavi S Cell Biochem Biophys. 2024; 82(4):3157-3208.

PMID: 39150676 DOI: 10.1007/s12013-024-01447-x.

Zinc-Modified Titanate Nanotubes as Radiosensitizers for Glioblastoma: Enhancing Radiotherapy Efficacy and Monte Carlo Simulations.

Diz F, Monteiro W, Silveira I, Ruano D, Zotti E, Weimer R ACS Omega. 2024; 9(27):29499-29515.

PMID: 39005768 PMC: 11238320. DOI: 10.1021/acsomega.4c02125.

References

Zhang W, Fei Z, Zhen H, Zhang J, Zhang X . Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells. J Neurooncol. 2006; 81(3):231-40. DOI: 10.1007/s11060-006-9226-x. View

Heiss E, Schilder Y, Dirsch V . Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J Biol Chem. 2007; 282(37):26759-26766. DOI: 10.1074/jbc.M703229200. View

Schlachterman A, Valle F, Wall K, Azios N, Castillo L, Morell L . Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol. 2008; 1(1):19-27. PMC: 2510765. DOI: 10.1593/tlo.07100. View

Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View

Ahmad N, Adhami V, Afaq F, Feyes D, Mukhtar H . Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res. 2001; 7(5):1466-73. View

Kuo P, Chiang L, Lin C . Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 2002; 72(1):23-34. DOI: 10.1016/s0024-3205(02)02177-x. View

Ray P, Maulik G, Cordis G, Bertelli A, Bertelli A, Das D . The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med. 1999; 27(1-2):160-9. DOI: 10.1016/s0891-5849(99)00063-5. View

Campisi J, dAdda di Fagagna F . Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007; 8(9):729-40. DOI: 10.1038/nrm2233. View

Guillard S, Clarke P, Te Poele R, Mohri Z, Bjerke L, Valenti M . Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma. Cell Cycle. 2009; 8(3):443-53. DOI: 10.4161/cc.8.3.7643. View

10.

Seluanov A, Gorbunova V, Falcovitz A, Sigal A, Milyavsky M, Zurer I . Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. Mol Cell Biol. 2001; 21(5):1552-64. PMC: 86701. DOI: 10.1128/MCB.21.5.1552-1564.2001. View

11.

Braig M, Schmitt C . Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res. 2006; 66(6):2881-4. DOI: 10.1158/0008-5472.CAN-05-4006. View

12.

Lenz G, Goncalves D, Luo Z, Avruch J, Rodnight R, Neary J . Extracellular ATP stimulates an inhibitory pathway towards growth factor-induced cRaf-1 and MEKK activation in astrocyte cultures. J Neurochem. 2001; 77(4):1001-9. DOI: 10.1046/j.1471-4159.2001.00299.x. View

13.

Saul N, Pietsch K, Menzel R, Steinberg C . Quercetin-mediated longevity in Caenorhabditis elegans: is DAF-16 involved?. Mech Ageing Dev. 2008; 129(10):611-3. DOI: 10.1016/j.mad.2008.07.001. View

14.

Nam T, Yoo C, Kim H, Hwa Kwon C, Park J, Kim Y . The flavonoid quercetin induces apoptosis and inhibits migration through a MAPK-dependent mechanism in osteoblasts. J Bone Miner Metab. 2008; 26(6):551-60. DOI: 10.1007/s00774-008-0864-2. View

15.

Narayanan B, Narayanan N, Re G, Nixon D . Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer. 2003; 104(2):204-12. DOI: 10.1002/ijc.10932. View

16.

Mukhtar H, Ahmad N . Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol. 1999; 158(3):207-10. DOI: 10.1006/taap.1999.8721. View

17.

Tonn J, Goldbrunner R . Mechanisms of glioma cell invasion. Acta Neurochir Suppl. 2003; 88:163-7. DOI: 10.1007/978-3-7091-6090-9_22. View

18.

Ferry D, Smith A, Malkhandi J, Fyfe D, deTakats P, Anderson D . Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996; 2(4):659-68. View

19.

Saiko P, Szakmary A, Jaeger W, Szekeres T . Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat Res. 2007; 658(1-2):68-94. DOI: 10.1016/j.mrrev.2007.08.004. View

20.

de Boer V, Dihal A, van der Woude H, Arts I, Wolffram S, Alink G . Tissue distribution of quercetin in rats and pigs. J Nutr. 2005; 135(7):1718-25. DOI: 10.1093/jn/135.7.1718. View